Browsing: FDA

AdvaMed presents its priorities for fostering medical innovation, improving patient access, and strengthening the U.S. medtech industry’s global leadership.

A federal judge in Texas has rejected a request to allow compounding pharmacies to produce a popular weight loss medication, upholding the FDA’s authority on drug manufacturing.

An analysis of the evolving regulatory landscape surrounding AI and machine learning in healthcare, focusing on developments in the U.S., European Union, and China.

The Food and Drug Administration (FDA) has released new draft guidance for developers of medical devices that use artificial intelligence.

An analysis of potential repercussions stemming from reported staffing changes at the FDA, and the role of AI experts.

HeartBeam, a health technology company, is raising funds to support its FDA-cleared 12-lead ECG device.